Human Genome Epidemiology Literature Finder
|
Records 1 - 12 (of 12 Records) |
| Query Trace: Disease and AXL[original query] |
|---|
| Human vitamin K-dependent GAS6: gene structure, allelic variation, and association with stroke. Human mutation 2004 May 23 (5): 506-12. Muñoz X, Sumoy L, Ramírez-Lorca R, Villar J, de Frutos PG, Sala N |
| Polymorphisms in the receptor tyrosine kinase MERTK gene are associated with multiple sclerosis susceptibility. PloS one 2011 6 (2): e16964. Ma Gerry Z M, Stankovich Jim, , Kilpatrick Trevor J, Binder Michele D, Field Judi |
| Vitamin K-dependent proteins GAS6 and Protein S and TAM receptors in patients of systemic lupus erythematosus: correlation with common genetic variants and disease activity. Arthritis research & therapy 2013 Mar 15 (2): 2. Recarte-Pelz P, Tassies D, Espinosa G, Hurtado B, Sala N, Cervera R, Reverter JC, Garcia de Frutos P |
| Analysis of receptor tyrosine kinase genetics identifies two novel risk loci in GAS6 and PROS1 in Behçet's disease. Scientific reports 2016 6 26662. Qin Jieying, Li Lin, Zhang Donglei, Yu Hongsong, Tan Handan, Zhang Jun, Deng Bolin, Kijlstra Aize, Yang Peize |
| A window of opportunity study of potential tumor and soluble biomarkers of response to preoperative erlotinib in early stage non-small cell lung cancer. Oncotarget 2016 May 7 (18): 25632-9. Sacher Adrian G, Le Lisa W, Lara-Guerra Humberto, Waddell Thomas K, Sakashita Shingo, Chen Zhuo, Kim Lucia, Zhang Tong, Kamel-Reid Suzanne, Salvarrey Alexandra, Darling Gail, Yasufuku Kazuhiro, Keshavjee Shaf, de Perrot Marc, Shepherd Frances A, Liu Geoffrey, Tsao Ming Sound, Leighl Natasha |
| Expression level of CRKL and AXL combined with exon 19 deletion in EGFR and ALK status confer differential prognosis of lung adenocarcinoma subtypes. Oncology letters 2016 Nov 12 (5): 3312-3322. Cai Yi-Ran, Dong Yu-Jie, Wu Hong-Bo, Yu Da-Ping, Zhou Li-Juan, Su Dan, Zhang Li, Chen Xue-Ji |
| A phase Ib/II study of cabozantinib (XL184) with or without erlotinib in patients with non-small cell lung cancer. Cancer chemotherapy and pharmacology 2017 Mar . Wakelee Heather A, Gettinger Scott, Engelman Jeffrey, Jänne Pasi A, West Howard, Subramaniam Deepa S, Leach Joseph, Wax Michael, Yaron Yifah, Miles Dale R, Lara Primo |
| CSF protein changes associated with hippocampal sclerosis risk gene variants highlight impact of GRN/PGRN. Experimental gerontology 2017 Feb . Fardo David W, Katsumata Yuriko, Kauwe John S K, Deming Yuetiva, Harari Oscar, Cruchaga Carlos, , Nelson Peter |
| Levels and prognostic impact of circulating markers of inflammation, endothelial activation and extracellular matrix remodelling in patients with lung cancer and chronic obstructive pulmonary disease. BMC cancer 2018 Jul 18 (1): 739. Berg Janna, Halvorsen Ann Rita, Bengtson May-Bente, Taskén Kristin A, Mælandsmo Gunhild M, Yndestad Arne, Halvorsen Bente, Brustugun Odd Terje, Aukrust Pål, Ueland Thor, Helland Åsla |
| Phase 1 Study of Cabozantinib in Japanese Patients With Expansion Cohorts in Non-Small-Cell Lung Cancer. Clinical lung cancer 2019 2 20 (3): e317-e328. Nokihara Hiroshi, Nishio Makoto, Yamamoto Noboru, Fujiwara Yutaka, Horinouchi Hidehito, Kanda Shintaro, Horiike Atsushi, Ohyanagi Fumiyoshi, Yanagitani Noriko, Nguyen Linh, Yaron Yifah, Borgman Anne, Tamura Tomohi |
| Phase I results of S49076 plus gefitinib in patients with EGFR TKI-resistant non-small cell lung cancer harbouring MET/AXL dysregulation. Lung cancer (Amsterdam, Netherlands) 2021 4 155 127-135. Park Keunchil, Chang Gee-Chen, Curigliano Giuseppe, Lim Wan-Teck, Soo Ross A, Molina-Vila Miguel A, Cattan Valérie, Darville Hélène, Gandossi Eric, Smutna Veronika, Sudey Isabelle, Viteri Santia |
| Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development. Frontiers in immunology 2022 8 13 926236. Pipitone Rosaria Maria, Calvaruso Vincenza, Di Marco Lorenza, Di Salvo Francesca, Gaggianesi Miriam, Lupo Giulia, Zito Rossella, La Mantia Claudia, Ramazzotti Matteo, Petta Salvatore, Di Marco Vito, Craxì Antonio, Grimaudo Stefan |
- Page last reviewed:Feb 1, 2024
- Content source: